MeiraGTx Holdings (MGTX) Amortizatization of Intangibles (2022 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Amortizatization of Intangibles came in at $27000.0 in Q4 2025, up 104.39% YoY from $13210.0 in Q4 2024, and up 106.34% on a QoQ basis from -$426000.0 in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Amortizatization of Intangibles (2022 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 4 years of Amortizatization of Intangibles data on file, last reported at $27000.0 in Q4 2025.
- Quarterly Amortizatization of Intangibles rose 104.39% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $153000.0 (down 26.79% YoY) and the FY2025 annual result came in at $153000.0, down 26.79% from the prior year.
- Amortizatization of Intangibles climbed to $27000.0 in Q4 2025, from -$426000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $498000.0 in Q2 2024 to a low of -$615000.0 in Q4 2024.
- A 4-year average of $41307.7 and a median of $47000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 2450.0% — and 2024, when it plunged 1408.51%.
- Tracing MGTX's Amortizatization of Intangibles over 4 years: stood at -$2000.0 in 2022, then soared by 2450.0% to $47000.0 in 2023, then sank by 1408.51% to -$615000.0 in 2024, then jumped by 104.39% to $27000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $27000.0 (Q4 2025), -$426000.0 (Q3 2025), and $489000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Jun 30, 2025 | 278,000.00 |
| Mar 31, 2025 | 274,000.00 |
| Dec 31, 2024 | 279,000.00 |
| Sep 30, 2024 | 278,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Mar 31, 2024 | 273,000.00 |
| Dec 31, 2023 | 274,000.00 |
| Sep 30, 2023 | 271,000.00 |
| Jun 30, 2023 | 272,000.00 |
| Mar 31, 2023 | 266,000.00 |
| Dec 31, 2022 | 274,000.00 |